Testing DA-302168S for weight loss in overweight and obese adults
Part of Hormones & metabolism clinical trials.
This study tests a new medication called DA-302168S to help people lose weight. You may qualify if you're overweight or obese and meet certain health requirements.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18–75 years
- BMI of 28 or higher (obese), or 24–28 with a weight-related health condition like high blood pressure, prediabetes, or joint pain
- Weight has been stable (changed less than 5%) for the past 3 months while trying diet and exercise
- No type 1 or type 2 diabetes
- No history of weight-loss surgery or conditions affecting how your body absorbs medications
- No recent heart problems, severe psychiatric symptoms, or abnormal blood work
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medication, HDM1002, to help people with excess weight lose weight and keep it off. You may qualify if you have a high BMI or a lower BMI with weight-related health problems, and you have struggled to lose weight through diet and exercise alone.
This study tests a new medication called MDR-001 for helping people lose weight. It is for adults who are either obese or overweight with related health issues. The goal is to see if the drug is safe and effective for weight loss.
This trial tests an investigational weight-loss medication (MDR-001) for people who are overweight or have obesity. Researchers want to see if this drug helps with weight loss and is safe when taken along with diet and exercise.
This trial tests a new medication called DA-1726 for people with obesity but no other major health problems. It aims to see if the drug is safe and how it works in the body. You may qualify if your body mass index (BMI) is between 30 and 45 and your weight has been stable for 3 months.
This study tests a new medicine (NNC6989-0001) for people who are overweight or have obesity. It checks if the medicine is safe and how the body handles it. If eligible, you would receive the study drug and be monitored closely.
This study tests a new medication called KDS2010 for people who are overweight or have obesity. The goal is to see if it helps with weight loss when combined with diet and exercise.
Hear when a new Overweight and Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.